Literature DB >> 27437222

Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and ART Status.

R Thulasi Raman1, D Manimaran2, Praveen Rachakatla3, K Bharathi4, Tameem Afroz5, Radha Sagar6.   

Abstract

INTRODUCTION: HIV infection is known to cause coagulation abnormalities by various mechanism, especially during its late course. AIM: The objective of this study was to analyse platelet count, prothrombin time and activated partial thromboplastin time among HIV infected patients and to analyse these parameters with respect to their CD4 count and ART status.
MATERIALS AND METHODS: A case control study was conducted with 120 HIV infected patients and 40 normal individuals. The blood samples were collected after obtaining consent from the subjects. The blood samples were processed for platelet count, prothrombin time and activated partial thromboplastin time and CD4 count. The results were tabulated and analysed with statistical package.
RESULTS: The platelet count was significantly decreased in HIV infected patients compared to controls. Though HIV patients with CD4 count less than 200cells/mm(3) showed a decreased platelet count compared to those with CD4 count greater than 200cells/mm(3), it was not statistically significant. Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) was significantly prolonged in HIV patients, but only aPTT showed significant inverse correlation with CD4 count. None of the parameters showed statistical significance on comparing HIV patients on ART with those not on ART.
CONCLUSION: Basic coagulation tests like platelet count, PT and especially aPTT can be used as prospective screening test to assess severity in HIV patients in resource limited settings where CD4 count is not available.

Entities:  

Keywords:  Activated partial thromboplastin time; Anti-retroviral agents; Blood coagulation; Prothrombin time

Year:  2016        PMID: 27437222      PMCID: PMC4948398          DOI: 10.7860/JCDR/2016/17459.7718

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Serum concentrations of antiphospholipid and anticardiolipin antibodies are higher in HIV-infected women.

Authors:  Alireza Abdollahi; Afsaneh Morteza
Journal:  Rheumatol Int       Date:  2011-03-30       Impact factor: 2.631

2.  Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time.

Authors:  Myung S Park; Wenjun Z Martini; Michael A Dubick; Jose Salinas; Saulius Butenas; Bijan S Kheirabadi; Anthony E Pusateri; Jeffrey A Vos; Charles H Guymon; Steven E Wolf; Kenneth G Mann; John B Holcomb
Journal:  J Trauma       Date:  2009-08

3.  The utility of bone-marrow examination in HIV-infected adults in South Africa.

Authors:  A S Karstaedt; L Pantanowitz; T Omar; H E Sonnendecker; M Patel
Journal:  QJM       Date:  2001-02

4.  Effect of antiretroviral therapy on hemostasis in Brazilian pregnant women with HIV infection.

Authors:  Camila Marques de Andrade; Geraldo Duarte; Silvana Maria Quintana; Marlise Bonetti Agostinho Montes; Maria Regina Torqueti Toloi
Journal:  Blood Coagul Fibrinolysis       Date:  2007-12       Impact factor: 1.276

Review 5.  Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages.

Authors:  Mariola López; Jesús San Román; Vicente Estrada; Eugenia Vispo; Francisco Blanco; Vicente Soriano
Journal:  AIDS Rev       Date:  2012 Oct-Dec       Impact factor: 2.500

6.  HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cells.

Authors:  Jun Jiang; Weiping Fu; Xinwen Wang; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Cardiovasc Res       Date:  2010-01-18       Impact factor: 10.787

Review 7.  Thrombosis and a hypercoagulable state in HIV-infected patients.

Authors:  Yu-Min P Shen; Eugene P Frenkel
Journal:  Clin Appl Thromb Hemost       Date:  2004-07       Impact factor: 2.389

8.  Lupus anticoagulant in human immunodeficiency virus -infected patients on highly active antiretroviral therapy.

Authors:  Omolade A Awodu; Edeghonghon E Olayemi; Godwin N Bazuaye; Abel N Onunu
Journal:  Indian J Pathol Microbiol       Date:  2010 Jan-Mar       Impact factor: 0.740

9.  HIV-Associated Venous Thromboembolism.

Authors:  Michele Bibas; Gianluigi Biava; Andrea Antinori
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-07-08       Impact factor: 2.576

10.  An Acquired Factor VIII Inhibitor in a Patient with HIV and HCV: A Case Presentation and Literature Review.

Authors:  S B Zeichner; A Harris; G Turner; M Francavilla; J Lutzky
Journal:  Case Rep Hematol       Date:  2013-09-30
View more
  6 in total

Review 1.  Coagulation Parameters in Human Immunodeficiency Virus Infected Patients: A Systematic Review and Meta-Analysis.

Authors:  Solomon Getawa; Tiruneh Adane
Journal:  AIDS Res Treat       Date:  2022-04-21

2.  Effect of highly active antiretroviral therapy (HAART) on some specific clotting profile in Human Immunodeficiency Virus -(HIV) positive pregnant women.

Authors:  Osime Odaburhine Evarista; Tijani Paul Ezimokhai; Blessing Airiagbonbu
Journal:  Indian J Sex Transm Dis AIDS       Date:  2020-06-18

3.  CD56dim NK Cell is an Important Factor in T Cell Depletion of cART-Treated AIDS Patients.

Authors:  Feng Qian; Song Hu; Yueping Zhu; Yinling Wang; Jin Liu; Jialu Qiao; Xiji Shu; Yong Gao; Binlian Sun; Chuanwu Zhu
Journal:  Int J Gen Med       Date:  2022-05-03

Review 4.  The Role of HIV Infection in the Pathophysiology of Gestational Diabetes Mellitus and Hypertensive Disorders of Pregnancy.

Authors:  Wendy N Phoswa
Journal:  Front Cardiovasc Med       Date:  2021-05-12

5.  Basic Coagulation Parameters among Human Immunodeficiency Virus-Infected Adults in Gondar, Northwest Ethiopia: A Comparative Cross-Sectional Study.

Authors:  Masresha Seyoum; Bamlaku Enawgaw; Zegeye Getaneh; Getabalew Engidaye; Fikir Asrie; Mulugeta Melku
Journal:  Biomed Res Int       Date:  2018-05-15       Impact factor: 3.411

6.  Hemostasis in elderly patients with human immunodeficiency virus (HIV) infection-Cross-sectional study.

Authors:  Marilza Campos de Magalhães; Juan Camilo Sánchez-Arcila; Ana Carolina de Brito Lyra; Luiz Felipe Boufleur Long; Isabelle Vasconcellos de Souza; Fernando Raphael de Almeida Ferry; Adilson José de Almeida; Soniza Vieira Alves-Leon
Journal:  PLoS One       Date:  2020-02-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.